Global Peritoneal Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 117 pages | ID: GD6569DD82DGEN
GlobalInfoResearch

Abstracts

Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.

SCOPE OF THE REPORT:

This report studies the Peritoneal Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Peritoneal Cancer market by product type and applications/end industries.
Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladder and rectum.
The global Peritoneal Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Peritoneal Cancer.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• AstraZeneca
• GlaxoSmithKline
• Oxford BioMedica
• Millennium Pharmaceuticals
• Novartis
• Bayer
• Incyte
• EntreMed
• Oncolytics Biotech
• Synta Pharmaceuticals
• Oasmia Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Surgery
• Chemotherapy (Anticancer Drugs)
• Radiotherapy (High-Energy Rays)

Market Segment by Applications, can be divided into

• Cancer Research Centers
• Cancer Hospital
• Surgical Centers
• Clinics

Contents

1 PERITONEAL CANCER MARKET OVERVIEW

1.1 Product Overview and Scope of Peritoneal Cancer
1.2 Classification of Peritoneal Cancer by Types
  1.2.1 Global Peritoneal Cancer Revenue Comparison by Types (2017-2023)
  1.2.2 Global Peritoneal Cancer Revenue Market Share by Types in 2017
  1.2.3 Surgery
  1.2.4 Chemotherapy (Anticancer Drugs)
  1.2.5 Radiotherapy (High-Energy Rays)
1.3 Global Peritoneal Cancer Market by Application
  1.3.1 Global Peritoneal Cancer Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Cancer Research Centers
  1.3.3 Cancer Hospital
  1.3.4 Surgical Centers
  1.3.5 Clinics
1.4 Global Peritoneal Cancer Market by Regions
  1.4.1 Global Peritoneal Cancer Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Peritoneal Cancer Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Peritoneal Cancer Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Peritoneal Cancer Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Peritoneal Cancer Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Peritoneal Cancer Status and Prospect (2013-2023)
1.5 Global Market Size of Peritoneal Cancer (2013-2023)

2 MANUFACTURERS PROFILES

2.1 AstraZeneca
  2.1.1 Business Overview
  2.1.2 Peritoneal Cancer Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 AstraZeneca Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
  2.2.1 Business Overview
  2.2.2 Peritoneal Cancer Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 GlaxoSmithKline Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.3 Oxford BioMedica
  2.3.1 Business Overview
  2.3.2 Peritoneal Cancer Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Oxford BioMedica Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.4 Millennium Pharmaceuticals
  2.4.1 Business Overview
  2.4.2 Peritoneal Cancer Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Millennium Pharmaceuticals Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
  2.5.1 Business Overview
  2.5.2 Peritoneal Cancer Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Novartis Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
  2.6.1 Business Overview
  2.6.2 Peritoneal Cancer Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Bayer Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.7 Incyte
  2.7.1 Business Overview
  2.7.2 Peritoneal Cancer Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Incyte Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.8 EntreMed
  2.8.1 Business Overview
  2.8.2 Peritoneal Cancer Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 EntreMed Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.9 Oncolytics Biotech
  2.9.1 Business Overview
  2.9.2 Peritoneal Cancer Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Oncolytics Biotech Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.10 Synta Pharmaceuticals
  2.10.1 Business Overview
  2.10.2 Peritoneal Cancer Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Synta Pharmaceuticals Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.11 Oasmia Pharmaceutical
  2.11.1 Business Overview
  2.11.2 Peritoneal Cancer Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Oasmia Pharmaceutical Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PERITONEAL CANCER MARKET COMPETITION, BY PLAYERS

3.1 Global Peritoneal Cancer Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Peritoneal Cancer Players Market Share
  3.2.2 Top 10 Peritoneal Cancer Players Market Share
3.3 Market Competition Trend

4 GLOBAL PERITONEAL CANCER MARKET SIZE BY REGIONS

4.1 Global Peritoneal Cancer Revenue and Market Share by Regions
4.2 North America Peritoneal Cancer Revenue and Growth Rate (2013-2018)
4.3 Europe Peritoneal Cancer Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Peritoneal Cancer Revenue and Growth Rate (2013-2018)
4.5 South America Peritoneal Cancer Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Peritoneal Cancer Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PERITONEAL CANCER REVENUE BY COUNTRIES

5.1 North America Peritoneal Cancer Revenue by Countries (2013-2018)
5.2 USA Peritoneal Cancer Revenue and Growth Rate (2013-2018)
5.3 Canada Peritoneal Cancer Revenue and Growth Rate (2013-2018)
5.4 Mexico Peritoneal Cancer Revenue and Growth Rate (2013-2018)

6 EUROPE PERITONEAL CANCER REVENUE BY COUNTRIES

6.1 Europe Peritoneal Cancer Revenue by Countries (2013-2018)
6.2 Germany Peritoneal Cancer Revenue and Growth Rate (2013-2018)
6.3 UK Peritoneal Cancer Revenue and Growth Rate (2013-2018)
6.4 France Peritoneal Cancer Revenue and Growth Rate (2013-2018)
6.5 Russia Peritoneal Cancer Revenue and Growth Rate (2013-2018)
6.6 Italy Peritoneal Cancer Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC PERITONEAL CANCER REVENUE BY COUNTRIES

7.1 Asia-Pacific Peritoneal Cancer Revenue by Countries (2013-2018)
7.2 China Peritoneal Cancer Revenue and Growth Rate (2013-2018)
7.3 Japan Peritoneal Cancer Revenue and Growth Rate (2013-2018)
7.4 Korea Peritoneal Cancer Revenue and Growth Rate (2013-2018)
7.5 India Peritoneal Cancer Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Peritoneal Cancer Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA PERITONEAL CANCER REVENUE BY COUNTRIES

8.1 South America Peritoneal Cancer Revenue by Countries (2013-2018)
8.2 Brazil Peritoneal Cancer Revenue and Growth Rate (2013-2018)
8.3 Argentina Peritoneal Cancer Revenue and Growth Rate (2013-2018)
8.4 Colombia Peritoneal Cancer Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE PERITONEAL CANCER BY COUNTRIES

9.1 Middle East and Africa Peritoneal Cancer Revenue by Countries (2013-2018)
9.2 Saudi Arabia Peritoneal Cancer Revenue and Growth Rate (2013-2018)
9.3 UAE Peritoneal Cancer Revenue and Growth Rate (2013-2018)
9.4 Egypt Peritoneal Cancer Revenue and Growth Rate (2013-2018)
9.5 Nigeria Peritoneal Cancer Revenue and Growth Rate (2013-2018)
9.6 South Africa Peritoneal Cancer Revenue and Growth Rate (2013-2018)

10 GLOBAL PERITONEAL CANCER MARKET SEGMENT BY TYPE

10.1 Global Peritoneal Cancer Revenue and Market Share by Type (2013-2018)
10.2 Global Peritoneal Cancer Market Forecast by Type (2018-2023)
10.3 Surgery Revenue Growth Rate (2013-2023)
10.4 Chemotherapy (Anticancer Drugs) Revenue Growth Rate (2013-2023)
10.5 Radiotherapy (High-Energy Rays) Revenue Growth Rate (2013-2023)

11 GLOBAL PERITONEAL CANCER MARKET SEGMENT BY APPLICATION

11.1 Global Peritoneal Cancer Revenue Market Share by Application (2013-2018)
11.2 Peritoneal Cancer Market Forecast by Application (2018-2023)
11.3 Cancer Research Centers Revenue Growth (2013-2018)
11.4 Cancer Hospital Revenue Growth (2013-2018)
11.5 Surgical Centers Revenue Growth (2013-2018)
11.6 Clinics Revenue Growth (2013-2018)

12 GLOBAL PERITONEAL CANCER MARKET SIZE FORECAST (2018-2023)

12.1 Global Peritoneal Cancer Market Size Forecast (2018-2023)
12.2 Global Peritoneal Cancer Market Forecast by Regions (2018-2023)
12.3 North America Peritoneal Cancer Revenue Market Forecast (2018-2023)
12.4 Europe Peritoneal Cancer Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Peritoneal Cancer Revenue Market Forecast (2018-2023)
12.6 South America Peritoneal Cancer Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Peritoneal Cancer Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Peritoneal Cancer Picture
Table Product Specifications of Peritoneal Cancer
Table Global Peritoneal Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Peritoneal Cancer Revenue Market Share by Types in 2017
Figure Surgery Picture
Figure Chemotherapy (Anticancer Drugs) Picture
Figure Radiotherapy (High-Energy Rays) Picture
Table Global Peritoneal Cancer Revenue (Million USD) by Application (2013-2023)
Figure Peritoneal Cancer Revenue Market Share by Applications in 2017
Figure Cancer Research Centers Picture
Figure Cancer Hospital Picture
Figure Surgical Centers Picture
Figure Clinics Picture
Table Global Market Peritoneal Cancer Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Peritoneal Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Peritoneal Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Peritoneal Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Peritoneal Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Peritoneal Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Peritoneal Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Peritoneal Cancer Type and Applications
Table AstraZeneca Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Peritoneal Cancer Type and Applications
Table GlaxoSmithKline Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Oxford BioMedica Basic Information, Manufacturing Base and Competitors
Table Oxford BioMedica Peritoneal Cancer Type and Applications
Table Oxford BioMedica Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Millennium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Millennium Pharmaceuticals Peritoneal Cancer Type and Applications
Table Millennium Pharmaceuticals Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Peritoneal Cancer Type and Applications
Table Novartis Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Peritoneal Cancer Type and Applications
Table Bayer Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Incyte Basic Information, Manufacturing Base and Competitors
Table Incyte Peritoneal Cancer Type and Applications
Table Incyte Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table EntreMed Basic Information, Manufacturing Base and Competitors
Table EntreMed Peritoneal Cancer Type and Applications
Table EntreMed Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Oncolytics Biotech Basic Information, Manufacturing Base and Competitors
Table Oncolytics Biotech Peritoneal Cancer Type and Applications
Table Oncolytics Biotech Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Synta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Synta Pharmaceuticals Peritoneal Cancer Type and Applications
Table Synta Pharmaceuticals Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Oasmia Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Oasmia Pharmaceutical Peritoneal Cancer Type and Applications
Table Oasmia Pharmaceutical Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Global Peritoneal Cancer Revenue (Million USD) by Players (2013-2018)
Table Global Peritoneal Cancer Revenue Share by Players (2013-2018)
Figure Global Peritoneal Cancer Revenue Share by Players in 2016
Figure Global Peritoneal Cancer Revenue Share by Players in 2017
Figure Global Top 5 Players Peritoneal Cancer Revenue Market Share in 2017
Figure Global Top 10 Players Peritoneal Cancer Revenue Market Share in 2017
Figure Global Peritoneal Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Peritoneal Cancer Revenue (Million USD) by Regions (2013-2018)
Table Global Peritoneal Cancer Revenue Market Share by Regions (2013-2018)
Figure Global Peritoneal Cancer Revenue Market Share by Regions (2013-2018)
Figure Global Peritoneal Cancer Revenue Market Share by Regions in 2017
Figure North America Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Europe Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure South America Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Table North America Peritoneal Cancer Revenue by Countries (2013-2018)
Table North America Peritoneal Cancer Revenue Market Share by Countries (2013-2018)
Figure North America Peritoneal Cancer Revenue Market Share by Countries (2013-2018)
Figure North America Peritoneal Cancer Revenue Market Share by Countries in 2017
Figure USA Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Canada Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Mexico Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Table Europe Peritoneal Cancer Revenue (Million USD) by Countries (2013-2018)
Figure Europe Peritoneal Cancer Revenue Market Share by Countries (2013-2018)
Figure Europe Peritoneal Cancer Revenue Market Share by Countries in 2017
Figure Germany Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure UK Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure France Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Russia Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Italy Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Peritoneal Cancer Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Peritoneal Cancer Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Peritoneal Cancer Revenue Market Share by Countries in 2017
Figure China Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Japan Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Korea Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure India Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Table South America Peritoneal Cancer Revenue by Countries (2013-2018)
Table South America Peritoneal Cancer Revenue Market Share by Countries (2013-2018)
Figure South America Peritoneal Cancer Revenue Market Share by Countries (2013-2018)
Figure South America Peritoneal Cancer Revenue Market Share by Countries in 2017
Figure Brazil Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Argentina Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Colombia Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Peritoneal Cancer Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Peritoneal Cancer Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peritoneal Cancer Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peritoneal Cancer Revenue Market Share by Countries in 2017
Figure Saudi Arabia Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure UAE Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Egypt Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure Nigeria Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Figure South Africa Peritoneal Cancer Revenue and Growth Rate (2013-2018)
Table Global Peritoneal Cancer Revenue (Million USD) by Type (2013-2018)
Table Global Peritoneal Cancer Revenue Share by Type (2013-2018)
Figure Global Peritoneal Cancer Revenue Share by Type (2013-2018)
Figure Global Peritoneal Cancer Revenue Share by Type in 2017
Table Global Peritoneal Cancer Revenue Forecast by Type (2018-2023)
Figure Global Peritoneal Cancer Market Share Forecast by Type (2018-2023)
Figure Global Surgery Revenue Growth Rate (2013-2018)
Figure Global Chemotherapy (Anticancer Drugs) Revenue Growth Rate (2013-2018)
Figure Global Radiotherapy (High-Energy Rays) Revenue Growth Rate (2013-2018)
Table Global Peritoneal Cancer Revenue by Application (2013-2018)
Table Global Peritoneal Cancer Revenue Share by Application (2013-2018)
Figure Global Peritoneal Cancer Revenue Share by Application (2013-2018)
Figure Global Peritoneal Cancer Revenue Share by Application in 2017
Table Global Peritoneal Cancer Revenue Forecast by Application (2018-2023)
Figure Global Peritoneal Cancer Market Share Forecast by Application (2018-2023)
Figure Global Cancer Research Centers Revenue Growth Rate (2013-2018)
Figure Global Cancer Hospital Revenue Growth Rate (2013-2018)
Figure Global Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Peritoneal Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Peritoneal Cancer Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Peritoneal Cancer Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Peritoneal Cancer Revenue Market Forecast (2018-2023)
Figure Europe Peritoneal Cancer Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Peritoneal Cancer Revenue Market Forecast (2018-2023)
Figure South America Peritoneal Cancer Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Peritoneal Cancer Revenue Market Forecast (2018-2023)